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Supplementary Table 1: Number of cis-eGenes and independent cis-eQTLs.  
Cell type Treatment Sample 
size 
#eGenes #eGene-eSNP 
associations 
#eGenes with 
multiple independent 
eQTLs (proportion) 
#Independent 
eQTL signals 
Myeloid 
cells 
Resting 116 136 9462 1 (0.7%) 137 
LPS 125 376 25110 12 (3.2%) 386 
T cells 
Resting 126 971 68161 53 (5.5%) 1027 
PHA 127 1347 100091 85 (6.3%) 1436 
The number of independent eQTL signals were obtained from the conditional analysis. 
 
Supplementary Table 2: Trans-associations that are mediated by cis-eGenes.  
Condition eSNP 
Cis-
eGene 
Trans-
eGene 
Total 
Effect a b 
Mediation 
Effect (%) 
P-
value FDR 
Resting M 12:56435929 RPS26 MYH10 -1.00 -1.23 0.62 -0.77 (77.0%) <0.001 <0.001 
LPS M 12:56435929 RPS26 MYH10 -0.94 -1.10 0.22 -0.24 (25.7%) 0.015 0.035 
Resting T 12:56435929 RPS26 MYH10 -1.30 -1.38 0.20 -0.28 (21.5%) 0.006 0.026 
Resting T 12:56435929 RPS26 MIR130A -1.10 -1.38 0.26 -0.36 (32.5%) 0.019 0.039 
Resting T 12:56435929 RPS26 STX1B -1.13 -1.38 0.25 -0.35 (30.8%) 0.042 0.066 
Resting T 12:56389293 RPS26 MIR1471 0.79 1.28 0.02 0.02 (3.0%) 0.920 0.949 
Resting T 12:56435929 RPS26 IP6K2 -0.92 -1.38 0.36 -0.50 (54.2%) 0.009 0.032 
Resting T 12:56444632 SUOX MYH10 1.05 -0.47 -0.06 0.03 (2.7%) 0.506 0.643 
PHA T 12:56444632 SUOX MYH10 0.58 -0.56 0.13 -0.07 (-12.3%) 0.060 0.083 
Resting T 12:56444632 SUOX MIR130A 0.93 -0.47 0.02 -0.01 (-1.2%) 0.949 0.949 
PHA T 12:56435412 SUOX MIR130A 0.46 -0.56 0.13 -0.07 (-15.8%) 0.036 0.063 
Resting T 12:56444632 SUOX STX1B 0.92 -0.47 0.07 -0.03 (-3.5%) 0.702 0.819 
Resting T 4:119170256 SNHG8 MIR330 -1.03 -1.33 0.49 -0.65 (62.8%) 0.001 0.008 
PHA T 4:119170256 SNHG8 MIR330 -1.16 -1.25 0.42 -0.53 (45.7%) 0.014 0.035 
Rows in the table are the 14 mediation trios that were tested, with not significant ones (FDR >0.05) in grey. 
The “Condition” column indicates four groups, with “M” and “T” indicating myeloid cells and T cells, 
respectively, which were stimulated by either lipopolysaccharide (LPS) or phytohemagglutinin (PHA). The 
“eSNP” column indicates the lead SNP in each trans locus that are also associated with local genes (“Cis-
eGene”). The statistics were obtained from the bootstrap method. The column “Total Effect” shows the total 
effect of the eQTL on the trans-eGene; “a” indicates the effects of the eQTL on the mediator or the cis-
eGene; “b” indicates the effects of the cis-eGene on the trans-eGene controlling for the effect of the 
corresponding eQTL; “Mediation Effect (%)” indicates the indirect effect of the eQTL on the trans-eGene, 
which is a×b, with the proportion of mediation effect among total effect in brackets. Benjamini-Hochberg 
FDR controlling procedure was applied to correct for multiple testing. 
  
Supplementary Table 3: P-values of the enrichment analysis in Supplementary Figure 6. 
 Resting M LPS M Resting T PHA T 
Allergic disease 6.3E-245 1.6E-156 8.3E-108 2.0E-74 
Allergic rhinitis 0.999 0.998 0.997 0.996 
Allergic sensitisation 0.974 0.971 0.970 0.570 
Asthma 3.8E-10 1.7E-07 1.7E-15 5.7E-09 
Asthma (adult) 1.1E-49 1.6E-46 1.4E-41 8.0E-29 
Asthma (childhood) 1.1E-61 8.2E-51 3.3E-34 3.6E-28 
IBD 5.1E-168 1.2E-102 2.3E-149 1.8E-150 
Crohn's disease 4.7E-06 2.2E-26 6.6E-53 2.8E-82 
Ulcerative colitis 1.8E-248 1.0E-195 2.8E-165 5.0E-199 
Celiac disease 0.999 0.998 0.033 0.118 
Celiac disease (ic) 4.3E-09 6.0E-06 2.9E-09 1.6E-07 
ATD (ic) 1.5E-44 1.3E-37 8.8E-43 4.7E-112 
JIA (ic) 6.9E-10 3.1E-06 1.2E-04 1.3E-03 
Multiple sclerosis (ic) 1.9E-09 6.0E-09 4.0E-10 8.1E-06 
Narcolepsy (ic) 3.9E-05 6.7E-04 0.014 0.998 
PBC 4.1E-165 2.8E-152 7.4E-112 2.6E-126 
PBC (ic) 1.4E-17 1.5E-09 5.3E-07 4.0E-13 
PSC 9.9E-20 2.2E-19 6.3E-25 1.9E-24 
Psoriasis (ic) 1.9E-04 8.3E-04 1.1E-05 5.8E-06 
RA 1.2E-32 7.7E-35 4.4E-34 1.8E-31 
RA (ic) 7.0E-13 2.1E-07 3.4E-06 2.5E-10 
SLE 4.0E-56 8.4E-50 6.6E-47 2.4E-50 
Type 1 diabetes 6.0E-192 2.2E-195 1.7E-182 3.7E-292 
Type 1 diabetes (ic) 2.5E-21 3.5E-27 6.3E-12 9.5E-05 
Edu attainment 1.2E-03 0.938 2.6E-04 6.9E-08 
This table contains the exact P-values calculated from the enrichment analysis. Enrichment was tested for 
each of the four sets of cis-eQTLs separately (“M” and “T” indicate myeloid cells and T cells, respectively). 
The enrichment effect sizes and confidence intervals are in Supplementary Figure 6. The enrichment was 
estimated using significant eSNPs identified in resting myeloid cells (n=9,116 SNPs), LPS-stimulated 
myeloid cells (n=24,255 SNPs), resting T cells (n=65,147 SNPs), and PHA-stimulated T cells (n=92,378 
SNPs). P-values that are not significant after Bonferroni correction are in grey. We used genome-wide 
association studies investigating allergic diseases (asthma, hay fever, or eczema)1, allergic rhinitis2, allergic 
sensitisation2, asthma3, adult-onset asthma4, childhood-onset asthma4, Inflammatory bowel disease (IBD)5, 
Crohn’s disease5, and ulcerative colitis5, celiac disease6,7, autoimmune thyroid disease (ATD)8, juvenile 
idiopathic arthritis (JIA)9, multiple scleraosis10, narcolepsy11, primary biliary cirrhosis (PBC)12,13, primary 
sclerosing cholangitis (PSC)14, psoriasis15, rheumatoid arthritis (RA)16,17, systemic lupus erythematosus 
(SLE)18, type 1 diabetes19,20, and educational attainment21 that serves as a negative control. Each row 
represents one disease, with “ic” indicating that the study was performed using ImmunoChip array. 
 
Supplementary Figure 1: Inferred cell type abundances from gene expression data. We performed 
tissue deconvolution analysis using CIBERSORTx (web-based) to estimate the cell type abundances of 
samples from four cell cultures. Relevant cell types are shown in the plots: panel A (LPS-stimulated 
myeloid-cell-enriched cultures) shows the estimated proportions of all myeloid cells that are available in 
the CIBERSORTx reference transcriptome profiles, namely monocytes, macrophages, dendritic cells, and 
mast cells; panel B shows the estimated proportions of various T cell types in the PHA-stimulated T-cell-
enriched cultures. Results of resting cultures, which are not shown here, also were estimated to have high 
proportions: median=70.3% in resting myeloid-cell-enriched cultures and median=75.8% in resting T-cell-
enriched cultures. Each bar in the plots represent one sample, and colours indicate different inferred cell 
types. Gene expression data that were quantile normalised across all 557 samples that passed QC from four 
cultures were used, and samples that were included in the eQTL analysis are shown here. 
 
 
 
Supplementary Figure 2: Distribution of the number of detected genes per microarray sample. Colour 
indicates four experimental conditions. Number in brackets indicates the average number of detected genes 
(Methods) within each group. 
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 Supplementary Figure 3: Condition specificity of eQTLs. (A) the heatmap shows eQTL sharing across 
four experimental conditions (rows) using conditional analysis (Methods). Columns in the heatmap are 
unique eQTL–eGene associations. Significant associations are in red. Percentages labelled on the heatmap 
show the proportion of unique eQTL–eGene associations that are specific to a certain cell type and 
stimulatory condition. We also used a multivariate adaptive shrinkage (mash) model to compare eQTL 
signals across the four datasets (Methods), and the Venn diagrams (B) show the overlap of the condition-
specific signals identified using these two methods.  
 
Supplementary Figure 4: Enrichment of cis-eQTLs in 3’UTR, 5’UTR, and exon regions. Data are 
presented as logarithm of Odds Ratio (OR), estimated at various eQTL significance levels from 1´10-3 to 
1´10-7, and its 95% confidence intervals (CIs). The number of SNPs that were used to estimate OR and CIs 
are shown in the plot. GARFILED accepts only one p-value threshold while the nominal p-value thresholds 
used to determine significant eQTLs vary across genes. In each row, four plots show the enrichment of cis-
eQTL SNPs identified in four experimental conditions (“M” and “T” indicate myeloid cells and T cells, 
respectively). Tests that were significant after the Bonferroni correction are marked by red asterisks, where 
a P-value threshold of 0.0018 was used, adjusting for the 7´4 (28) tests. 
 
 
 
 
 
Supplementary Figure 5: Response eQTLs (reQTLs) with flipped directions of effects on gene 
expression across conditions. ReQTLs of DDT (A) and ZNF585 (B) show opposite directions of eQTL 
effects. (A) Two boxplots show associations of rs5751775 (top eSNP in resting T cells) with DDT expression 
in resting (left) and PHA-stimulated (right) T cells. Dots indicate individuals stratified by genotypes (x-axes) 
and the rank-normalised gene expression is shown on y-axes. The centre line corresponds to median, and 
the lower and upper hinges indicate the 25th and 75th percentiles. The upper whisker extends from the hinge 
to the largest value ≤1.5 * inter-quartile range (IQR) from the hinge, and the lower whisker extends from the 
hinge to the smallest value at most 1.5 * IQR of the hinge. The highest and lowest dots show the maximum 
and minimum gene expression. Similarly, panel (B) shows the associations of rs13068288 (top eSNP in 
PHA-stimulated T cells) with ZNF589 expression. Chromosome number and genomic position in 
hg19/GRCh37 are in brackets next to the SNP rsID. Effect sizes of these associations are shown under each 
boxplot, which is the number of s.d. of gene expression increased per allele dosage. For both panels, 126 
and 127 biologically independent samples were used to identify eQTLs and estimate effect sizes in resting 
and PHA-stimulated T cells, respectively.  
 
 
  
 
Supplementary Figure 6: Enrichment of early-life cis-eQTLs for genetic variants associated with 
immune-related diseases. We used genome-wide association studies investigating allergic diseases (asthma, 
hay fever, or eczema)1, allergic rhinitis2, allergic sensitisation2, asthma3, adult-onset asthma4, childhood-
onset asthma4, Inflammatory bowel disease (IBD)5, Crohn’s disease5, and ulcerative colitis5, celiac disease6,7, 
autoimmune thyroid disease (ATD)8, juvenile idiopathic arthritis (JIA)9, multiple scleraosis10, narcolepsy11, 
primary biliary cirrhosis (PBC)12,13, primary sclerosing cholangitis (PSC)14, psoriasis15, rheumatoid arthritis 
(RA)16,17, systemic lupus erythematosus (SLE)18, type 1 diabetes19,20, and educational attainment21 that 
serves as a negative control. Each plot represents one disease, with “ic” indicating that the study was 
performed using ImmunoChip array. Enrichment was tested for each of the four sets of cis-eQTLs separately 
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(x-axes: “M” and “T” indicate myeloid cells and T cells, respectively). Height of each bar indicates the 
enrichment effect size or logarithm of the odds ratio (centre of error bars) with 95% confidence intervals 
(CIs) shown as the error bars. The enrichment was estimated using significant eSNPs identified in resting 
myeloid cells (n=9,116 SNPs), LPS-stimulated myeloid cells (n=24,255 SNPs), resting T cells (n=65,147 
SNPs), and PHA-stimulated T cells (n=92,378 SNPs). Tests that are not significant at P-value 0.05 are not 
shown since the beta estimates are not reliable and the CIs are too large. Colour of each bar indicates the 
significance level based on minus log10 P-values; the same colour is used if the P-value is smaller than 1´10-
25 (the exact P-values are in Supplementary Table 3). Asterisks indicate that the tests are significant after 
Bonferroni correction for multiple testing. 
 
 
 
 
Supplementary Figure 7: Colocalisation of the cis-eQTL of BACH2 with multiple diseases. Six regional 
plots show eQTL association with BACH2 expression in resting T cells (purple background), and GWAS 
associations with autoimmune thyroid disease (ATD), celiac disease, multiple sclerosis, rheumatoid arthritis 
(RA), and type 1 diabetes (white background). “ic” indicates that the GWAS was performed using 
ImmunoChip array. The minus log10 P-value is plotted on y-axes for SNPs located within 200 kb from the 
top eSNP of BACH2 (rs72928038). The regional plots for GWAS signals show SNPs that are available in 
both datasets (i.e. SNPs that were tested in the colocalisation analysis), and the first eQTL plot shows all 
SNPs in the CAS dataset. Colours of dots indicate the LD r2 correlation with the top eSNP (purple). Positions 
of genes located on this locus are shown at the bottom. BACH2 did not have significant cis-eQTLs in the 
other three experimental conditions. We used n=126 biologically independent samples to identify eQTLs 
and estimate effect sizes in resting T cells. 
 
  
 Supplementary Figure 8: Colocalisation between the response eQTL (reQTL) of CCL20 and 
childhood-onset asthma association. (A) Regional plots show eQTL association with CCL20 expression 
in PHA-stimulated T cells (purple background), and GWAS association with childhood-onset asthma (white 
background). The minus log10 P-value is plotted on y-axes for SNPs located within 200 kb from the top 
eSNP of CCL20 (rs13034664). The second plot for the GWAS signal shows SNPs that are available in both 
datasets (i.e. SNPs that were tested in the colocalisation analysis), and the first eQTL plot shows all SNPs in 
the CAS dataset. Colours of dots indicate the LD r2 correlation with the top eSNP (purple) based on CAS 
genotype data. Positions of genes located on this locus are shown at the bottom. CCL20 did not have 
significant cis-eQTLs in the other three experimental conditions. (B) Boxplots show the rank-normalised 
CCL20 expression (y-axes) in resting (left) and stimulated (right) T cells stratified by genotypes of the reQTL 
(x-axes). The centre line corresponds to median, and the lower and upper hinges indicate the 25th and 75th 
percentiles. The upper whisker extends from the hinge to the largest value ≤1.5 * inter-quartile range (IQR) 
from the hinge, and the lower whisker extends from the hinge to the smallest value at most 1.5 * IQR of the 
hinge. The highest and lowest dots show the maximum and minimum gene expression. In resting T cells, no 
SNP was significantly associated with CCL20. We used n=126 and 127 biologically independent samples to 
identify eQTLs and estimate effect sizes in resting and PHA-stimulated T cells, respectively. 
 
  
 
Supplementary Figure 9: Colocalisations with different diseases are observed for the CTSH cis-eQTLs 
identified in resting (left) and stimulated (right) cells. On the left, regional plots show eQTL associations 
(purple background) with CTSH expression identified in resting myeloid cells (Resting M) and resting T 
cells (Resting T). The two eQTL signals have the same top eSNP rs34593439, and both colocalised with 
GWAS hits associated with celiac disease, narcolepsy, and type 1 diabetes (white background). “ic” indicates 
that the GWAS was performed using ImmunoChip array. On the right, regional plots show eQTL 
associations (purple background) with CTSH expression identified in LPS-stimulated myeloid cells (LPS M; 
top eSNP rs11638844) and PHA-stimulated T cells (PHA T). They both colocalised with GWAS signal for 
primary biliary cirrhosis (PBC; white background). The minus log10 P-value is plotted on y-axes for SNPs 
located within 200 kb from the corresponding top eSNP (left: rs34593439; right: rs11638844). The regional 
plots for GWAS signals show SNPs that are available in both datasets (i.e. SNPs that were tested in the 
colocalisation analysis), and the regional plots for eQTLs show all SNPs in the CAS dataset. Colours of dots 
indicate the LD r2 correlation with the top eSNP (purple). Positions of genes located on this locus are shown 
at the bottom. We used n=116, 125, 126 and 127 biologically independent samples to identify eQTLs and 
estimate effect sizes in resting myeloid cells, LPS-stimulated myeloid cells, resting T cells, and PHA-
stimulated T cells, respectively.  
 
Supplementary Figure 10: Causal associations (negative) between BTN3A2 expression and immune-
related diseases. Data are presented as cis-eQTL effect sizes (centre) with 95% confidence intervals (CIs) 
on x-axes and genetic effect sizes of SNPs (centre) on disease risk with 95% CIs on y-axes. Cis-eQTL effect 
sizes were estimated from resting T cells (left; n=126 biologically independent samples) and PHA-stimulated 
T cells (right; n=127). Rows show immune-related diseases that were negatively associated with BTN3A2 
expression (PSC: primary sclerosing cholangitis; SLE: systemic lupus erythematosus). In each plot, four 
fitted lines indicate different Mendelian randomisation methods and ribbons indicate their 95% confidence 
intervals (IVW: inverse variance weighted; Methods).  
 
 
 
 
Supplementary Figure 11: Causal associations (positive) between BTN3A2 expression and immune-
related diseases. Data are presented as cis-eQTL effect sizes (centre) with 95% confidence intervals (CIs) 
on x-axes and genetic effect sizes of SNPs (centre) on disease risk with 95% CIs on y-axes. Cis-eQTL effect 
sizes were estimated from resting T cells (left; n=126 biologically independent samples) and PHA-stimulated 
T cells (right; n=127). Rows show immune-related diseases that were positively associated with BTN3A2 
expression (PBC: primary biliary cirrhosis; IBD: inflammatory bowel disease). In each plot, four fitted lines 
indicate different Mendelian randomisation methods and ribbons indicate their 95% confidence intervals 
(IVW: inverse variance weighted; Methods). The plot for causal effects of BTN3A2 expression in stimulated 
T cells on IBD is missing because the number of available genetic instruments was too low (<3) to perform 
various Mendelian randomisation methods.  
 
  
 
Supplementary Figure 12: Colocalisation between the cis-eQTLs of BTN3A2 in four experimental 
conditions with primary biliary cirrhosis (PBC). Five regional plots show eQTL associations (purple 
background) with BTN3A2 expression in four conditions (“M” and “T” indicate myeloid cells and T cells, 
respectively), and GWAS association with PBC (white background). “ic” indicates that the GWAS was 
performed using ImmunoChip array. The minus log10 P-value is plotted on y-axes for SNPs located within 
200 kb from rs9393710, which was the top SNP of the GWAS hit. rs9393710 was among the top eSNPs 
identified in resting and stimulated myeloid cells and in resting T cells, and the top eSNP in stimulated T 
cells was in high LD with it (r2 = 0.92). The regional plot for the GWAS signal shows SNPs that are available 
in both datasets (i.e. SNPs that were tested in the colocalisation analysis), and the regional plots for eQTLs 
show all SNPs in the CAS dataset. Colours of dots indicate the LD r2 correlation with the top eSNP (purple) 
based on CAS genotype data. Positions of genes located on this locus are shown at the bottom. We used 
n=116, 125, 126 and 127 biologically independent samples to identify eQTLs and estimate effect sizes in 
resting myeloid cells, LPS-stimulated myeloid cells, resting T cells, and PHA-stimulated T cells, 
respectively. 
 Supplementary Figure 13: Regional plot of the cis-eQTL of HLA-C and GWAS signals on the same 
locus. We plotted the diseases that were significantly associated with HLA-C expression in Mendelian 
Randomisation analysis. The top two plots show the eQTL associations (purple background) in LPS-
stimulated myeloid cells, and resting T cells, which share the same lead eQTL SNP (rs9264904). The rest 
three plots show GWAS associations with inflammatory bowel disease (IBD), juvenile idiopathic arthritis 
(JIA) and Psoriasis (white background), and “ic” indicates that the GWAS was performed using 
ImmunoChip array. The minus log10 P-value is plotted on y-axes for SNPs located within 200 kb from 
rs9264904. The regional plots for GWAS signals show SNPs that are available in both datasets (i.e. SNPs 
that were tested in the colocalisation analysis), and the regional plots for eQTLs show all SNPs in the CAS 
dataset. Colours of dots indicate the LD r2 correlation with the top eSNP (purple) based on CAS genotype 
data. Positions of genes located on this locus are shown at the bottom. We used n=125 and 126 biologically 
independent samples to identify eQTLs and estimate effect sizes in LPS-stimulated myeloid cells and resting 
T cells, respectively. 
 
 Supplementary Figure 14: Regional plot of the cis-eQTL of HLA-C and GWAS signals on the same 
locus. We plotted the diseases that were significantly associated with HLA-C expression in Mendelian 
Randomisation analysis. The first plot shows the eQTL association (purple background) in PHA-stimulated 
T cell, with the lead eQTL SNP (rs2853946) in purple. The rest regional plots show GWAS associations 
with multiple sclerosis, primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), rheumatoid 
arthritis (RA), systemic lupus erythematosus (SLE), and ulcerative colitis (white background), and “ic” 
indicates that the GWAS was performed using ImmunoChip array. The minus log10 P-value is plotted on 
y-axes for SNPs located within 200 kb from rs2853946. The regional plots for GWAS signals show SNPs 
that are available in both datasets (i.e. SNPs that were tested in the colocalisation analysis), and the regional 
eQTL plot shows all SNPs in the CAS dataset. Colours of dots indicate the LD r2 correlation with the top 
eSNP (purple) based on CAS genotype data. Positions of genes located on this locus are shown at the bottom. 
 
  
 
Supplementary Figure 15: Principal component analysis (PCA) of gene expression data. Each dot 
represents one sample from four different experimental conditions. Gene expression data used for PCA were 
quantile normalised across all 557 samples that passed QC. PCs were calculated using the 494 samples that 
are included the eQTL analysis (i.e. samples from individuals with genotype data available). First two PCs 
are plotted, and the proportion of variation explained by each PC is shown.  
 
 
 
Supplementary Figure 16: QC and normalisation pipeline. Steps where data processing was performed 
for four cell cultures separately are in green box. There were 576 samples from 152 individuals that went 
through the Illumina microarray platform, and 557 of them passed QC steps. For eQTL analysis, we used 
494 microarray samples from 135 individuals with genotype data available.  
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